Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial

Clicks: 360
ID: 114510
1998
Antiviral chemotherapy with famciclovir results in clinically and statistically significant reductions in the symptoms associated with HSV infection and the symptomatic and asymptomatic shedding of HSV among HIV-positive persons.
Reference Key
t1998annalsfamciclovir Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Schacker T;Hu HL;Koelle DM;Zeh J;Saltzman R;Boon R;Shaughnessy M;Barnum G;Corey L;;
Journal annals of internal medicine
Year 1998
DOI DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9424977
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't u.s. gov't adult female male aged middle aged P.H.S. regression analysis Clinical Trial Randomized Controlled Trial Antibodies Double-Blind Method Proportional Hazards Models viral / blood l corey antiviral agents / therapeutic use* cd4 lymphocyte count cross-over studies virus activation virus shedding aids-related opportunistic infections / drug therapy* pmid:9424977 doi:10.7326/0003-4819-128-1-199801010-00004 t schacker h l hu 2-aminopurine / analogs & derivatives* 2-aminopurine / therapeutic use aids-related opportunistic infections / virology famciclovir herpes simplex / drug therapy* herpes simplex / virology simplexvirus / growth & development

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.